European Archives - Page 86 of 994 - European Medical Journal

Continue
Martina Dempsey Astellas

Astellas’ Martina Dempsey on achieving equal footing for women in pharma

Martina Dempsey, VP of Commercial Strategy and Operations at Astellas Europe, discusses empowering women in the pharmaceutical industry.
15 Oct 2024

“Did you know” 2024 Podcast Series

Moderated by Sue Saville. With speakers: Prof Dr Frank Broekmans, Prof Peter Humaidan, Prof Dr Dominic Stoop, Dr Samuel Santos-Ribeiro…
15 Oct 2024

Electronic Nudges Boost Flu Vaccination in
Chronically Ill Patients

A study has demonstrated that electronic letters informed by behavioural science can significantly increase influenza vaccination rates in chronically ill patients.
Cartoon of London houses of parliament

Britain explores Eli Lilly’s obesity drug to tackle long-term sickness

The British government is set to explore whether Eli Lilly’s weight-loss drug could play a pivotal role in getting people back to work.
15 Oct 2024

Novel Procedure May Eliminate Insulin Dependency in Type 2 Diabetes - UEG Week 2024

Pioneering research presented at UEG Week 2024 has revealed a new treatment approach for Type 2 diabetes that could reduce the need for insulin therapy.  
15 Oct 2024

New Imaging Technique Shows Promise for Personalised Oesophageal Cancer Treatment – UEG Week 2024

A study presented at UEGW 2024 is exploring a breakthrough imaging technique aimed at improving treatment outcomes for patients with locally advanced oesophageal cancer.
15 Oct 2024

Biomarkers for Dementia Vary Depending on the Time of Day

New research has revealed that biomarker levels, particularly p-tau217, vary depending on the time of day, which could impact their clinical applicability.
15 Oct 2024

Predicting Progression of Barrett's Oesophagus with Genomic Markers – UEG Week 2024

At UEG Week 2024, researchers showed that TP53 mutations and chromosomal changes improve prediction of oesophageal adenocarcinoma in low-risk Barrett’s oesophagus.
Handshake on blue background

Lundbeck to acquire Longboard and potential blockbuster epilepsy drug

Lundbeck will acquire Longboard Pharmaceuticals, aiming to strengthen its portfolio with its potential blockbuster epilepsy treatment.
14 Oct 2024

Study Identifies Pre-diagnostic Antibody Signatures in IBD – UEG Week 2024

A groundbreaking study presented at UEG Week 2024 has revealed distinct antibody responses in Crohn’s disease and ulcerative colitis apparent years before diagnosis.